Page results
-
There are just a few days left to share your views as part of a public consultation on proposed changes to how and where maternity, neonatal, and children’s surgical services could be provided in North Central London. The consultation closes on Sunday, 17 March 2024.
-
Zero carbon, virtual appointments, specialist advice in primary care settings, thousands using online services, remote monitoring and digitising admin tasks: these are just some of the ways we will achieve patient-centred, integrated, excellent care for our patients as set out in our new outpatient strategy.
-
UCLH has teamed up with Air Ambulance Kent Surrey Sussex (KSS) to create an additional module to its Airway Matters, Massive Open Online Course (MOOC).
-
Health and wellbeing information for people affected by cancer.
-
Health and wellbeing information for people affected by cancer.
-
We run dedicated follow up clinics for brain injured patients, either following discharge from hospital or the emergency department.
-
Contractual screening for NGOs, Governmental organisations, academic institutions and private companies. Pre-assignment health reviews for medical fitness to travel
-
This page has been written for patients who have been recommended hormone therapy for prostate cancer. It explains what the treatment involves, describes side-effects you may experience, and how best to cope with them.
-
This patient information contains contraceptive advice for patients who have received Sugammadex.
-
A drop-in service providing support, practical advice and information.
File results
-
FOI/2023/0522 - Urology cancer pathway
-
FOI/2023/0523 - Treatment on Nivolumab
-
FOI/2023/0537 - Agency usage for the Occupational Therapy
-
FOI/2023/0542 - Pulmonary rehabilitation (PR)
-
FOI/2023/0550 - Varicose veins referrals, treatment and wait time
-
FOI/2023/0553 - Maternity complaints by ethnicity
-
FOI/2023/0559 - Patients admitted to hospital with dental distress
-
FOI/2023/0560 - Digital maternity training platform
-
FOI/2023/0561 - Birthrate Plus
-
FOI/2023/0563 - Treatment for Haemophilia B and Von Willebrand disease